Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03637257

Carbon Dioxide (CO2) Measurement With a CO2/O2 Guedel Airway

Measurement of Expired Carbon Dioxide: Comparison of a Modified CO2/O2 Guedel Airway With a Nasal Cannula in Sedated Children Aged 4-24 Months

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
4 Months – 24 Months
Healthy volunteers
Accepted

Summary

This trial compares capnographic signals using a modified CO2/O2 Guedel airway with a CO2/O2 nasal cannula without and with oxygen supply in sedated children aged 4 - 24 months.

Detailed description

Sedation of pediatric patients is frequently jeopardized by respiratory adverse events such as central and/or obstructive apnea resulting in hypoxemia. Various factors such as patient comorbidities, medication and inconsistent physiologic monitoring are known to contribute to or facilitate adverse events during sedation. Therefore, monitoring of breathing by capnography is recommended and has become common standard e.g. by the use of a CO2/O2 nasal cannula. However, capnography derived from CO2/O2 nasal cannulas may be impaired and these impairments are exaggerated in infants based on their physiologic characteristics (small tidal volumes, high respiratory rates). To overcome these impairments, the investigators developed a modified CO2/O2 Guedel airway including a CO2 sampling port at the tip of the airway. In a previous study, significantly more accurate capnographic signals resulted compared with measurements derived from a nasal cannula when using a modified CO2/O2 Guedel airway in a model of a breathing 6-month-old manikin. The aim of the study is to examine the accuracy of capnographic measurements of the modified CO2/O2 Guedel airway in comparison with measurements from a CO2/O2 nasal cannula in sedated children aged 4 - 24 months.

Conditions

Interventions

TypeNameDescription
DEVICEmodified Guedel airwayMonitoring of breathing

Timeline

Start date
2020-11-01
Primary completion
2021-01-01
Completion
2021-01-01
First posted
2018-08-17
Last updated
2020-11-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03637257. Inclusion in this directory is not an endorsement.